Our Transactions

Our Transactions

Locust Walk has closed high value transactions for multiple clients across a variety of therapeutic areas and modalities. Examples of recent client engagements where Locust Walk Securities served as a transaction advisor are listed below. We would encourage you to click on each case study and/or press release to learn about each assignment in greater detail. Don’t hesitate to contact us should you want to learn more about any transaction.

Locust_Armetheon

CLIENT: Armetheon

PARTNER: Investors

TRANSACTION:
Series B Financing of $24M

View press release »

Strongbridge_Antisense

CLIENT: Strongbridge
Biopharma

PARTNER: Antisense Therapeutics

TRANSACTION:
Buy-side licensing agreement for ALT1103 for Acromegaly

View case study »

Stonebridge_Logo_Website

CLIENT: Strongbridge
Biopharma

PARTNER: Investors

TRANSACTION:
Private Placement of $26.4M

View case study »

View press release »

CLIENT: Fabrus

PARTNER: Senesco

TRANSACTION:
Merger between Fabrus and Senesco Technologies

View case study »

Locust_Armetheon

CLIENT: Armetheon

PARTNER: Investors

TRANSACTION:

Series A Financing of $7M

View press release »

Locust_Teso_Aspen

CLIENT: TesoRx

PARTNER: Aspen

TRANSACTION:
Regional License Agreement and Investment for an Oral Unmodified Testosterone Replacement.

View case study »

Stonebridge_Logo_Website

CLIENT: Strongbridge Biopharma

PARTNER: Investors

TRANSACTION:

Private Placement of $33.2M

View case study »